No Data
Zhejiang Canaan Technology Limited (SZSE:300412) Stock Catapults 25% Though Its Price And Business Still Lag The Industry
Zhejiang Canaan Technology: Half-year report for the year 2024.
Zhejiang Canaan Technology: Summary of Half-Year Report in 2024.
As of August 9, 2024, the number of shareholders in zhejiang canaan technology (300412.SZ) was 27,683.
As of August 9, 2024, there were 27,683 shareholders of Zhejiang Canaan Technology (300412.SZ), as stated on the investor interaction platform of the company.
As of July 31, 2024, there were 27,983 shareholders of zhejiang canaan technology (300412.SZ) company.
As of July 31st, 2024, there are 27,983 shareholders in Zhejiang Canaan Technology (300412.SZ) according to the company's investor platform.
Zhejiang Canaan Technology (300412.SZ): the company's clients include Tasly Pharmaceutical Group, China Resources, etc.
On August 8th, Gelunhui reported that Zhejiang Canaan Technology (300412.SZ) stated on their investor interaction platform that the majority of their customers are well-known international and domestic companies in the pharmaceutical industry, including Tasly Pharmaceutical Group and China Resources.
Zhejiang Canaan Technology Limited (SZSE:300412) Surges 42% Yet Its Low P/S Is No Reason For ExcitementNo Data
